---
title: "Revolution Medicines tumbles 10% as biotech sector sells off"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301299588.md"
description: "RVMD tumbled 10% in regular trading as biotech weakness dragged shares lower; LifeSci Capital maintains Buy, $315 PT."
datetime: "2026-10-08T15:40:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301299588.md)
  - [en](https://longbridge.com/en/news/301299588.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301299588.md)
generator: "portal-rs"
---

# Revolution Medicines tumbles 10% as biotech sector sells off

Revolution Medicines(RVMD.US) 盘中跌 10.04%，现报**180.705 美元**。

生物科技板块遭遇普跌，Moderna、Vaxcyte 等个股均遭大幅抛售，RVMD 亦受板块情绪拖累。LifeSci Capital 分析师维持对 RVMD 的买入评级，目标价**315 美元**，认为其 RAS 产品管线动能强劲。公司近期启动针对一线转移性 RAS G12D 胰腺癌的 RASONQUE 与 zoldonrasib 联合用药第三期临床试验，ESMO GI 2026 数据显示其可改善患者生存率。

### Related Stocks

- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)

## Related News & Research

- [Revolution Medicines Q3 revenue reaches $198 mln after RASONQUE launch](https://longbridge.com/en/news/304336160.md)
- [Revolution's Rasonque improves survival across subgroups in pancreatic cancer patients](https://longbridge.com/en/news/302871272.md)
- [Apple Says It Will Keep Paying More for Memory Chips After December. That's Good News for Micron Stock.](https://longbridge.com/en/news/304212722.md)
- [Qualcomm Stock Price Forecast: QCOM Nears $160 Support Ahead of Earnings, Could Fall Another 13%](https://longbridge.com/en/news/304222632.md)
- [Earnings to watch: Coherent (COHR) reports Q3 results tomorrow](https://longbridge.com/en/news/304045735.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**